Durvalumab With or Without Metformin in Treating Participants With Head and Neck Squamous Cell Carcinoma

Conditions:   Larynx;   Lip, Oral Cavity and Pharynx
Interventions:   Drug: Metformin;   Biological: Durvalumab
Sponsor:   Sidney Kimmel Cancer Center at Thomas Jefferson University
Not yet recruiting

https://ift.tt/2M1ZmmE